Formulation and Drug Delivery, Biologic Drugs

Piramal Introduces Proof of Concept Service for Next Wave of ADC Growth

September 29, 2015

PTSM: Pharmaceutical Technology Sourcing and Management

The CDMO is striving to become a market leader in the development and manufacturing of antibody-drug conjugates.

Trends in Biologics Drug Delivery

September 25, 2015

There is growing interest in the development of liquid formulations in prefilled syringes and autoinjectors, which offer convenience and ease of administration in a home setting.

Catalent and Sanofi to Collaborate on ADC Development

January 15, 2015

Catalent Pharma Solutions and Sanofi-Aventis R&D have entered into a collaboration to develop Sanofi’s proprietary antibodies using Catalent’s SMARTag antibody drug conjugate (ADC) platform.

Drug Delivery Technologies Provide Growth Opportunities for Biopharmaceuticals

April 01, 2014

PTSM: Pharmaceutical Technology Sourcing and Management

Advanced drug delivery technologies can increase efficacy and safety, extend patent lives, and provide competitive differentiation for biopharmaceuticals.

Optimizing Drug Delivery for Modern Biologics

May 02, 2012

The author discusses potential opportunities to improve the patient experience through formulation and delivery device technologies.